Tilray Brands Inc

Tilray Brands Inc(TLRY)股票分析

$3.210

+0.072 (+2.23%)收盤時

Loading chart…
最高
3.280
開盤
3.090
成交量加權均價
3.19
成交量
2.67M
市值
1.43B
最低
3.070
成交金額
8.51M
企業價值/稅息折舊攤銷前利潤(TTM)
128.35

Tilray Brands, Inc. is a lifestyle consumer products company, which focuses on providing research-backed medical cannabis products to physicians, pharmacies, and patients around the world. The Company operates in four segments, which include cannabis operations, which encompasses the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. Beverage operations, which encompasses the production, marketing, and sale of beverage products. Distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers, and Wellness products, which encompasses wellness and better-for-you foods and beverages. It offers a portfolio of brands and products across medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods. It also owns digital healthcare and patient engagement platform, focused on medical cannabis education, physician consultations, and patient support services.

AI 分析 of Tilray Brands Inc (TLRY)

賣出

Tilray Brands Inc is not a good buy right now due to significant financial losses and declining stock performance. The current price is $3.54, and the stock has dropped 63.58% year-to-date. Additionally, the RSI is at 26.854, indicating it is oversold, but this does not guarantee a price recovery in the near term.

分析師評級(3)

上檔空間 +198.13%
買進
3 買進
0 持有
0 賣出
目前: 3.21
最低
8.50
平均
9.57
最高
10.00

TD Cowen

2026-07-14

目標價

$5

買進

Canaccord

2026-04-02

目標價

$13

持有

Roth Capital

2026-04-01

目標價

$10

買進

Alliance Global

2026-04-01

目標價

$7

中性

TD Cowen

2026-03-30

目標價

$7

買進

估值指標

Tilray Brands Inc(TLRY)目前預期本益比為 1000.00,5 年平均預期本益比為 154.07。

預期本益比

嚴重高估
5 年均值 P/E
154.07
目前P/E
1000.00
高估
551.73
低估
-243.60

預期 EV/EBITDA

嚴重高估
5 年均值 EV/EBITDA
24.77
目前EV/EBITDA
128.35
高估
46.49
低估
3.06

預期股價營收比

低估
5 年均值 P/S
2.13
目前P/S
0.40
高估
3.82
低估
0.44

Alphio AI 對 TLRY 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%TLRY

$0.55

情境價格

基

基準

基準 · 50%TLRY

$0.49

情境價格

悲

悲觀

悲觀 · 25%TLRY

$0.44

情境價格

事件時間軸

2026-10-08 (ET)

16:30:00

Major Averages Decline Amid Rising Oil Prices

12:30:00

Major Averages Decline as Oil Prices Surge

09:00:00

Stock Futures Lower as Oil Prices and Treasury Yields Rise

07:30:00

Company Reaffirms FY2027 Adjusted EBITDA Expectation of $68M to $75M

07:30:00

Tilray Brands Reports Q1 Revenue of $257.15M

資訊

TLRY 常見問題 —— 由 Alphio AI 解答

Tilray Brands, Inc. is a lifestyle consumer products company, which focuses on providing research-backed medical cannabis products to physicians, pharmacies, and patients around the world. The Company operates in four segments, which include cannabis operations, which encompasses the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. Beverage operations, which encompasses the production, marketing, and sale of beverage products. Distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers, and Wellness products, which encompasses wellness and better-for-you foods and beverages. It offers a portfolio of brands and products across medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods. It also owns digital healthcare and patient engagement platform, focused on medical cannabis education, physician consultations, and patient support services. It operates in the Healthcare sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Tilray Brands Inc is not a good buy right now due to significant financial losses and declining stock performance. The current price is $3.54, and the stock has dropped 63.58% year-to-date. Additionally, the RSI is at 26.854, indicating it is oversold, but this does not guarantee a price recovery in the near term.

3 analysts cover TLRY: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 9.57.

$TLRY is moving forward with its strategic transformation. From expanding its diversified portfolio to improving operational efficiencies and pursuing new growth opportunities, Tilray Brands is laying the groundwork for a stronger future. Can these strategic moves support sustainable growth and drive the stock's next rally? What's your take?

展開
lunarviper2026/9/24

🚀 $TLRY is moving into its next growth phase with a diversified push across cannabis, beverages, hospitality and wellness. 🌿🍺 Management is targeting $68M-75M in FY27 adjusted EBITDA, while BrewDog integration, international cannabis expansion and brand scaling remain key priorities. 💰 Tilray ended FY26 with about $235M in cash and securities and just $0.7M in net debt, giving it financial flexibility to keep investing in growth. 📈🔥

展開
註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易